Abbott reports positive Simcor trial results

11/4/2007 | CNNMoney

Abbott Laboratories' cholesterol-lowering treatment Simcor significantly reduced "bad" LDL cholesterol and improved "good" HDL cholesterol compared to simvastatin during its Phase III clinical trial. The company hopes to get regulatory approval for Simcor, a combination of simvastatin and another drug from Abbott, during the first quarter of 2008.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI